6
Participants
Start Date
April 30, 2009
Primary Completion Date
May 31, 2011
Study Completion Date
May 31, 2011
Lenalidomide
10 mg/day in cohort 1, and 25 mg/day in cohort 2. LEN is administered orally in standard 21 day cycles starting one week before each DC injection and ending 14 days after each DC injection. All patients will receive a total of three cycles of LEN.
Monocyte derived DCs loaded with KRN7000
10 million DCs injected intravenously
Yale University School of Medicine, New Haven
Collaborators (1)
Kyowa Kirin Co., Ltd.
INDUSTRY
Celgene
INDUSTRY
Yale University
OTHER